🇺🇸 FDA
Patent

US 11590221

Dengue vaccine unit dose and administration thereof

granted A61KA61K2039/5254A61K2039/545

Quick answer

US patent 11590221 (Dengue vaccine unit dose and administration thereof) held by Takeda Vaccines, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5254, A61K2039/545, A61K2039/572, A61K2039/575